Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Pepper

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Cell Death & Disease|August 16, 2025
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCLAimilia Vareli, Haripriya Vaidehi Narayanan, Heather Clark, et al.
Cancers|April 12, 2022
Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic LeukemiaThomas A Burley, Andrew Hesketh, Giselda Bucca, et al.
Molecular Oncology|August 10, 2019
Targeting CDK9 for treatment of colorectal cancerMuhammed H Rahaman, Frankie Lam, Longjin Zhong, et al.
Haematologica|May 9, 2020
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancersThomas Lewis, David B Corcoran, David E Thurston, et al.
British Journal of Haematology|April 25, 2009
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rateJulio Delgado, Guy Pratt, Neil Phillips, et al.
British Journal of Haematology|June 21, 2012
Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cellsEmma Hamilton, Laurence Pearce, Liam Morgan, et al.
British Journal of Haematology|March 26, 2017
Telomere length is a critical determinant for survival in multiple myelomaSam Hyatt, Rhiannon E Jones, Nicole H Heppel, et al.
Oncotarget|October 4, 2014
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73Frankie Lam, Abdullahi Y Abbas, Hao Shao, et al.
Cancer Research|August 26, 2010
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcriptionAndrea G S Buggins, Chris Pepper, Piers E M Patten, et al.
British Journal of Haematology|May 10, 2017
Telomere length is an independent prognostic marker in MDS but not in de novo AMLJenna Williams, Nicole H Heppel, Bethan Britt-Compton, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Cell Death & Disease|August 16, 2025
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCLAimilia Vareli, Haripriya Vaidehi Narayanan, Heather Clark, et al.
Cancers|April 12, 2022
Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic LeukemiaThomas A Burley, Andrew Hesketh, Giselda Bucca, et al.
Molecular Oncology|August 10, 2019
Targeting CDK9 for treatment of colorectal cancerMuhammed H Rahaman, Frankie Lam, Longjin Zhong, et al.
Haematologica|May 9, 2020
Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancersThomas Lewis, David B Corcoran, David E Thurston, et al.
British Journal of Haematology|April 25, 2009
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rateJulio Delgado, Guy Pratt, Neil Phillips, et al.
British Journal of Haematology|June 21, 2012
Mimicking the tumour microenvironment: three different co-culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia cellsEmma Hamilton, Laurence Pearce, Liam Morgan, et al.
British Journal of Haematology|March 26, 2017
Telomere length is a critical determinant for survival in multiple myelomaSam Hyatt, Rhiannon E Jones, Nicole H Heppel, et al.
Oncotarget|October 4, 2014
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73Frankie Lam, Abdullahi Y Abbas, Hao Shao, et al.
Cancer Research|August 26, 2010
Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcriptionAndrea G S Buggins, Chris Pepper, Piers E M Patten, et al.
British Journal of Haematology|May 10, 2017
Telomere length is an independent prognostic marker in MDS but not in de novo AMLJenna Williams, Nicole H Heppel, Bethan Britt-Compton, et al.
Pageof 12